Diabetes Management
Comprehensive solutions for blood glucose management, insulin support, and diabetic complication prevention across all patient profiles.
77M+
Diabetics in India
#1
Global diabetes capital
50%
Cases undiagnosed
2×
Higher CVD risk
Clinical Overview
The Diabetes Management challenge in India
India bears the largest diabetes burden in the world, with over 77 million adults diagnosed and an equal number estimated to remain undiagnosed. Diabetes is no longer a disease of affluence — it affects every socioeconomic stratum, cutting across urban and rural populations alike.
Effective management demands a multi-pronged pharmacological strategy. From first-line metformin to modern DPP-4 inhibitors, SGLT2 inhibitors, and GLP-1 receptor agonists, Q-Check's Diabetes portfolio gives physicians the full therapeutic toolkit — each product optimised for bioavailability, patient compliance, and safety across diverse patient profiles.
Conditions Covered
What we treat
Our Portfolio
Diabetes Management Products
12 products in this therapy area
HydroCheck
Ben Q Met
Dapacheck
